Khanna, D., Maher, T. M., Volkmann, E. R., Allanore, Y., Smith, V., Assassi, S., . . . Denton, C. P. (2023). Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. RMD Open, 9, . https://doi.org/10.1136/rmdopen-2022-002859
Chicago-Zitierstil (17. Ausg.)Khanna, Dinesh, et al. "Effect of Nintedanib in Patients with Systemic Sclerosis-associated Interstitial Lung Disease and Risk Factors for Rapid Progression." RMD Open 9 (2023). https://doi.org/10.1136/rmdopen-2022-002859.
MLA-Zitierstil (9. Ausg.)Khanna, Dinesh, et al. "Effect of Nintedanib in Patients with Systemic Sclerosis-associated Interstitial Lung Disease and Risk Factors for Rapid Progression." RMD Open, vol. 9, 2023, https://doi.org/10.1136/rmdopen-2022-002859.